Amitriptyline–perphenazine therapy for persistent idiopathic facial pain: translational perspectives from a retrospective study
2024

Amitriptyline and Perphenazine for Facial Pain

Sample size: 31 publication 10 minutes Evidence: moderate

Author Information

Author(s): Marchesini Maurizio, Topi Giulia, Bonezzi Cesare, Demartini Laura

Primary Institution: Department of Anesthesia and Pain Medicine, Mater Olbia Hospital, Olbia, Italy

Hypothesis

Can a combination of amitriptyline and perphenazine effectively reduce pain in patients with persistent idiopathic facial pain?

Conclusion

The combination of amitriptyline and perphenazine significantly improved pain scores and quality of life in patients with persistent idiopathic facial pain.

Supporting Evidence

  • Pain scores significantly decreased after treatment.
  • The number of pain attacks also reduced significantly.
  • Quality of life improved as measured by the SF-36 questionnaire.

Takeaway

This study found that a mix of two medicines helped people with facial pain feel better and have less pain.

Methodology

Retrospective observational study analyzing pain intensity and quality of life in patients treated with a fixed-dose combination of amitriptyline and perphenazine.

Potential Biases

Potential bias due to retrospective nature and lack of control group.

Limitations

Small sample size and retrospective design limit generalizability; no long-term follow-up.

Participant Demographics

31 patients, 80% women, average age 51 years.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 4.6–5.3

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/s44158-024-00217-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication